InvestorsHub Logo
Followers 9
Posts 1540
Boards Moderated 0
Alias Born 10/28/2017

Re: None

Tuesday, 09/04/2018 2:04:54 PM

Tuesday, September 04, 2018 2:04:54 PM

Post# of 6939
There are quite of few companies engaged in R & D of anti-body drug conjugates (ADCs). What makes Sesn's different? Anyone know or can point me in the direction of an answer?